48
CellSource
4880.T·TSETokyo JPFounded 2015300 employees
Small CapbiotechPublicMusculoskeletal
Platform: PFC Regen Med
Market Cap
$0.4B
All Drugs
2
Clinical Trials
6
Failed / Terminated
4
FDA Approved
1
Stock Price & Catalysts (4880.T)
Loading 4880.T stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| 488-6595 | 488-6595 | Approved | 4 | CDK4/6 | GISTGBM | ||
| 488-733 | 488-733 | Phase 1/2 | 2 | KRASG12C | Celiac |
SEC Filings & Financial Documents
SEC filings are not available for TSE-listed companies.
CellSource trades on TSE (JP). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (5)